A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes.

Diabetes care

Volumn 25, Issue 11, 2002, Pages 2058-2064

  St John Sutton, Martin ^a   Rendell, Marc ^a   Dandona, Paresh ^a   Dole, J F ^a   Murphy, Karen ^a   Patwardhan, Rita ^a   Patel, Jai ^a   Freed, Martin ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLYCOSYLATED HEMOGLOBIN; PLACEBO; ROSIGLITAZONE; THIAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; RACE; RANDOMIZED CONTROLLED TRIAL; SAFETY; TIME;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; FEMALE; GLYBURIDE; HEMODYNAMIC PROCESSES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PLACEBOS; SAFETY; THIAZOLES; THIAZOLIDINEDIONES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0036833805     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.11.2058     Document Type: Article

References (0)